Clinical efficacy and safety of evolocumab for low-density lipoprotein cholesterol reduction

Clinical efficacy and safety of evolocumab for low-density lipoprotein cholesterol reduction

Courtney A Henry, Ronald A Lyon, Hua Ling Department of Pharmacy Practice, School of Pharmacy, Hampton University, Hampton, VA, USA Abstract: Multiple categories of medications have been developed to manage lipid profiles and reduce the risk of cardiovascular events in patients with heart disease....

Full description

Bibliographic Details
Main Authors: Henry CA, Lyon RA, Ling H
Format: Article
Language:English
Published: Dove Medical Press 2016-04-01
Series:Vascular Health and Risk Management
Subjects:
PCSK9
hyperlipidemia
evolocumab
LDL-C
familial hypercholesterolemia
Online Access:https://www.dovepress.com/clinical-efficacy-and-safety-of-evolocumab-for-low-density-lipoprotein-peer-reviewed-article-VHRM

Internet

https://www.dovepress.com/clinical-efficacy-and-safety-of-evolocumab-for-low-density-lipoprotein-peer-reviewed-article-VHRM

Similar Items